Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuoran Tian

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|February 8, 2021
Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in CancerShuoran Tian, Junzhong Lai, Tingting Yu, et al.
Frontiers in Pharmacology|December 6, 2021
Therapeutic Development by Targeting the cGAS-STING Pathway in Autoimmune Disease and CancerQiumei Li, Shuoran Tian, Jiadi Liang, et al.
Frontiers in Pharmacology|March 18, 2020
Compound C Reducing Interferon Expression by Inhibiting cGAMP AccumulationJunzhong Lai, Xuan Luo, Shuoran Tian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 11, 2021
Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in miceJunzhong Lai, Yajuan Fu, Shuoran Tian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Stabilization of TGF-β Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-β Signaling Pathway to Maintain Liver Cancer Stemness and Drug ResistanceKewei Liu, Fanxuan Tian, Xu Chen, et al.
Nature Cell Biology|April 3, 2026
Aberrant amino acid-sensing promotes immunotherapy resistance via the inflammatory cytokine-ZBTB5-mTORC1 axisJunyu Xiang, Tao Wang, Shuoran Tian, et al.
Medcomm|October 30, 2024
Reduced intestinal-to-diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinomaLei Wang, Linghong Wan, Xu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II TrialLei Wang, Mengting Sun, Jinyang Li, et al.
Cancer Research|September 25, 2025
TRIM49 Deficiency Stabilizes a Galectin-3/EGR1 Transcriptional Complex that Drives Invasiveness of Gastric AdenocarcinomaZhong-Yi Qin, Lin-Rong Che, Shuoran Tian, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|February 8, 2021
Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in CancerShuoran Tian, Junzhong Lai, Tingting Yu, et al.
Frontiers in Pharmacology|December 6, 2021
Therapeutic Development by Targeting the cGAS-STING Pathway in Autoimmune Disease and CancerQiumei Li, Shuoran Tian, Jiadi Liang, et al.
Frontiers in Pharmacology|March 18, 2020
Compound C Reducing Interferon Expression by Inhibiting cGAMP AccumulationJunzhong Lai, Xuan Luo, Shuoran Tian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 11, 2021
Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in miceJunzhong Lai, Yajuan Fu, Shuoran Tian, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Stabilization of TGF-β Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-β Signaling Pathway to Maintain Liver Cancer Stemness and Drug ResistanceKewei Liu, Fanxuan Tian, Xu Chen, et al.
Nature Cell Biology|April 3, 2026
Aberrant amino acid-sensing promotes immunotherapy resistance via the inflammatory cytokine-ZBTB5-mTORC1 axisJunyu Xiang, Tao Wang, Shuoran Tian, et al.
Medcomm|October 30, 2024
Reduced intestinal-to-diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinomaLei Wang, Linghong Wan, Xu Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II TrialLei Wang, Mengting Sun, Jinyang Li, et al.
Cancer Research|September 25, 2025
TRIM49 Deficiency Stabilizes a Galectin-3/EGR1 Transcriptional Complex that Drives Invasiveness of Gastric AdenocarcinomaZhong-Yi Qin, Lin-Rong Che, Shuoran Tian, et al.
Pageof 1